Vertex Pharmaceuticals
| Use attributes for filter ! | |
| Stock price | VRTX |
|---|---|
| Disclaimer | |
| Headquarters | Boston |
| Massachusetts | |
| United States | |
| Ceo | Jeffrey Leiden |
| Revenue | 3. 04 billion USD (2018) |
| CFO | Charles F. Wagner |
| Unified actions | Save |
| Address | 2 Kingdom St, London W2 6BD, United Kingdom |
| Hours | Closed ⋅ Opens 9 AM |
| Phone | +44 20 3204 5100 |
| Sideways refinements | Alfasigma Poland Sp. o.o. |
| VIDI Pharma Sp. z o.o. | |
| AVRIX PHARMA sp. z o.o. | |
| Vygoris Limited | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 942352 |
About Vertex Pharmaceuticals
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Where is the Vertex Pharmaceuticals
Sickle cell: ‘The revolutionary gene-editing treatment that gave me new life'
... Jimi s stem cells were sent to Vertex Pharmaceuticals laboratories where the genetic editing would take place...
Cystic fibrosis drug given green light in England
... NHS England reached a deal with Orkambi manufacturers Vertex Pharmaceuticals after months of talks...
New drugs for cystic fibrosis patients in Scotland
... The agreement has been reached after extensive discussions between the Scottish government and Vertex Pharmaceuticals and means the medicines will now be made available to patients on the NHS in Scotland, subject to a confidential discount, she added...
Cystic fibrosis drugs rejected for use by NHS in Scotland
... While talk of further negotiation between Vertex Pharmaceuticals and the Scottish government is positive, people living in Scotland need these life-saving drugs now, he said...
'Deadlock must end' over cystic fibrosis drug Orkambi
... Crown UseThe manufacturers Vertex Pharmaceuticals want the NHS to pay £105,000 per patient per year, and have rejected the NHS s offer of £500m over five years...
